Recent advances in percutaneous coronary intervention.
Stephen P HoolePaul BambroughPublished in: Heart (British Cardiac Society) (2020)
Percutaneous coronary intervention (PCI) continues to advance at pace with an ever-broadening indication. In this article we will review the recent technological advances in PCI that have enabled more complex coronary disease to be treated. The choice of revascularisation strategy must take into account the evidence-just because we can treat by PCI does not necessarily mean we should. When PCI is indicated, a safe, precision PCI approach guided by physiology, imaging and optimal lesion preparation should be the goal to obtain complete revascularisation and a durable long-term result. When these standards are adhered to, the outcomes can be excellent, in even complex coronary disease. We provide contemporary trial evidence to justify PCI and treatment algorithms that ensure optimal revascularisation decision making to achieve the best patient outcomes.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- acute coronary syndrome
- coronary artery bypass grafting
- atrial fibrillation
- decision making
- coronary artery bypass
- coronary artery
- randomized controlled trial
- heart failure
- type diabetes
- high resolution
- aortic stenosis
- machine learning
- adipose tissue
- deep learning
- ejection fraction
- phase iii
- glycemic control
- aortic valve
- skeletal muscle